Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  van de Berga, Wilma D J ^a   Hepp, Dagmar H ^a   Dijkstra, Anke A ^a   Rozemuller, J Annemieke M ^a,b   Berendse, Henk W ^a   Foncke, E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS BRAIN BANK   (Netherlands)

Author keywords

Autopsy; Dementia; Disease progression; Incidental Lewy body disease; Tremor

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE TRANSPORTER;

AGING; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; AMYLOID PLAQUE; ARTICLE; COGNITIVE DEFECT; CORRELATION FUNCTION; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; INCIDENCE; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; OLFACTORY BULB; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; STAGING; SUBSTANTIA NIGRA; SURVIVAL TIME; SYNUCLEINOPATHY; TREMOR; VASCULAR AMYLOIDOSIS;

ALPHA-SYNUCLEIN; ANIMALS; DISEASE PROGRESSION; HUMANS; INCIDENTAL FINDINGS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; TREMOR;

EID: 84857784061     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 2009;8:1150-57.
2. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24:197-211.
3. Beach TG, White CL, III, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, et al. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 2009;117:169-74.
4. Parkkinen L, Pirttila T, Alafuzoff I. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 2008;115:399-407.
5. Parkkinen L, Soininen H, Alafuzoff I. Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease. J Neuropathol Exp Neurol 2003;62:363-7.
6. Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK. Controversies over the staging of alpha-synuclein pathology in Parkinson's disease. Acta Neuropathol 2008;116:125-8.
7. Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging. Neuropathol Appl Neurobiol 2008;34:284-95.
8. Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort. Neurology 2008;25;70:1042-8.
9. Parkkinen L, Soininen H, Laakso M, Alafuzoff I. Alpha-synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol 2001;27: 314-25.
10. Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, et al. Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 2009;117:635-52.
11. Halliday G, Hely M, Reid W, Morris J. The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 2008;115:409-15.
12. DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, et al. Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 2008;65:1074-80.
13. Berendse HW, Roos DS, Raijmakers P, Doty RL. Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease. J Neurol Sci 2011 Jun 24.
14. Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005; 64:1404-10.
15. Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, et al. Alphasynuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000;54:1916-21.
16. Burke RE, Dauer WT, Vonsattel JP. A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol 2008;64:485-91.
17. Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005;76:343-8.
18. Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ. A clinicopathological study of subtypes in Parkinson's disease. Brain 2009;132:2947-57.
19. Compta Y, Parkkinen L, O'Sullivan SS, Vandrovcova J, Holton JL, Collins C, et al. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain 2011;134:1493-505.